NYSE: RMD - ResMed

Yield per half year: +31.29%
Sector: Healthcare

Share chart ResMed

Extended chart Simple chart
Financial Markets by TradingView

About

ResMed является калифорнийской компанией по производству медицинского оборудования. В первую очередь это касается оборудования, связанного с лечением нарушений дыхания, связанных со сном, включая апноэ во сне, хроническую обструктивную болезнь легких и другие респираторные заболевания

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Цена ао 242.25
P/E 43.58
P/S 6.76
P/BV 8.51
EV/EBITDA 22.23
Дивиденд ао 1.92
Див.доход ао 1.17
EBITDA 0.8435
Сайт http://www.resmed.com
Число акций ао 0.14746 млрд
Выручка 2.61
ISIN US7611521078
Валюта usd
IPO date 1995-06-02
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Change price per day: -0.8738% (252.92)
Change price per week: +2.38% (244.87)
Change price per month: +12.83% (222.21)
Change price per 3 month: +18.41% (211.73)
Change price per half year: +31.29% (190.96)
Change price per year: +69.81% (147.64)
Change price per 3 year: -4.65% (262.95)
Change price per 5 year: +24.5% (201.37)
Change price per 10 year: +385.4% (51.65)
Change price per year to date: +44.92% (173)
All parameters

Underestimation

Title Value Grade
P/S 7.49 1
P/BV 7.66 1
P/E 35.24 5
EV/EBITDA 24.62 5
Total: 4.5

Efficiency

Title Value Grade
ROA, % 15.15 5
ROE, % 23.96 7
Total: 6.83

Dividends

Title Value Grade
Div yield, % 1.0767 2.7
DSI 0.9286 9.29
Total: 5.62

Debt

Title Value Grade
Debt/EBITDA 1.1795 8
Total: 7.8

Growth impulse

Title Value Grade
Yield Revenue, % 61.69 8
Yield Ebitda, % 58.8 7
Yield EPS, % 117.5 10
Total: 8.2
More

Dividend, % Dividend Result of period Buy before Register closing date Payment before
0.22% 0.53 II кв. 2024 13.08.2024 15.08.2024 30.08.2024
0.21% 0.48 I кв. 2024 06.05.2024 08.05.2024 23.05.2024
0.23% 0.48 IV кв. 2023 05.02.2024 07.02.2024 22.02.2024
0.27% 0.48 II кв. 2023 14.08.2023 16.08.2023 31.08.2023
0.18% 0.44 II кв. 2022 15.08.2022 17.08.2022 01.09.2022
0.18% 0.42 IV кв. 2021 07.02.2022 09.02.2022 24.02.2022
0.18% 0.42 III кв. 2021 05.11.2021 09.11.2021 24.11.2021
0.16% 0.42 II кв. 2021 16.08.2021 18.08.2021 02.09.2021
0.18% 0.38 I кв. 2021 10.05.2021 12.05.2021 27.05.2021
0.19% 0.38 IV кв. 2020 08.02.2021 10.02.2021 25.02.2021
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
09.09.2024 10.09.2024 Farrell Michael J.
Chief Executive Officer		 Sale 248.38 3 646 960 14683 0 -0.01 link
09.09.2024 10.09.2024 Farrell Michael J.
Chief Executive Officer		 Purchase 84.98 1 247 760 14683 0 0.01 link
09.09.2024 10.09.2024 Sandercock Brett
Chief Financial Officer		 Sale 246.42 246 420 1000 0 0 link
07.06.2024 10.06.2024 Farrell Michael J.
Chief Executive Officer		 Sale 211.66 3 107 800 14683 0 -0.01 link
07.06.2024 10.06.2024 Farrell Michael J.
Chief Executive Officer		 Purchase 84.98 1 247 760 14683 0 0.01 link
08.05.2024 10.05.2024 Sandercock Brett
Chief Financial Officer		 Sale 211.37 2 747 810 13000 0 -0.01 link
08.05.2024 10.05.2024 Sandercock Brett
Chief Financial Officer		 Purchase 101.64 1 219 680 12000 0 0.01 link
04.03.2024 06.03.2024 Rider Michael J
Global General Counsel		 Sale 180 14 580 81 0 0 link
01.09.2023 07.09.2023 Rider Michael J
Global General Counsel		 Sale 161.15 4 029 25 0 0 link
17.07.2023 18.07.2023 Douglas Robert Andrew
President and COO		 Sale 222.22 333 330 1500 0 0 link
10.05.2023 12.05.2023 Sandercock Brett
Chief Financial Officer		 Sale 233.13 2 931 380 12574 0 -0.01 link
03.05.2023 04.05.2023 PENDARVIS DAVID
Chief Administrative Officer		 Sale 237.64 356 460 1500 0 0 link
24.04.2023 25.04.2023 Ghoshal Kaushik
President, SaaS Business		 Sale 230 460 000 2000 0 0 link
15.11.2022 16.11.2022 BLAISE LUCILE
President, Sleep & RC Business		 Sale 225.18 38 055 169 0 0 link
15.11.2022 16.11.2022 BLAISE LUCILE
President, Sleep & RC Business		 Purchase 225.18 116 193 516 0 0 link
14.10.2022 17.10.2022 Douglas Robert Andrew
President and COO		 Sale 215.09 2 442 350 11355 0 -0.01 link
14.10.2022 17.10.2022 Douglas Robert Andrew
President and COO		 Purchase 58.24 1 050 240 18033 0 0.01 link
15.09.2022 16.09.2022 Douglas Robert Andrew
President and COO		 Sale 232.38 1 394 280 6000 0 0 link
15.09.2022 16.09.2022 Douglas Robert Andrew
President and COO		 Sale 232.51 2 601 550 11189 0 -0.01 link
15.09.2022 16.09.2022 Douglas Robert Andrew
President and COO		 Purchase 58.24 1 050 240 18033 0 0.01 link
15.02.2022 16.02.2022 Farrell Michael J.
Chief Executive Officer		 Sale 234.06 1 328 290 5675 0 0 link
15.02.2022 16.02.2022 Farrell Michael J.
Chief Executive Officer		 Purchase 57.76 327 788 5675 0 0 link
03.02.2022 04.02.2022 PENDARVIS DAVID
Chief Administration Officer		 Sale 232.87 359 551 1544 0 0 link
22.11.2021 23.11.2021 Burt Carol
Director		 Sale 260 390 000 1500 0 0 link
01.10.2021 01.10.2021 Hollingshead James
President, Sleep Business		 Sale 261.33 627 192 2400 0 0 link
20.08.2021 23.08.2021 Sandercock Brett
Chief Financial Officer		 Sale 281.73 3 024 650 10736 0 -0.01 link
20.08.2021 23.08.2021 Sandercock Brett
Chief Financial Officer		 Purchase 57.76 620 111 10736 0 0.01 link
10.05.2021 11.05.2021 Sandercock Brett
Chief Financial Officer		 Sale 196 490 000 2500 0 0 link
24.11.2020 25.11.2020 Sandercock Brett
Chief Financial Officer		 Sale 211 1 055 000 5000 0 0 link
05.11.2020 13.11.2020 Leong Justin
President, Asia Latin America		 Sale 211.36 1 635 930 7740 0 -0.01 link
05.11.2020 13.11.2020 Leong Justin
President, Asia Latin America		 Purchase 57.76 447 062 7740 0 0.01 link

Institutions Volume Share, %
Vanguard Group Inc 17743457 12.06
Blackrock Inc. 12248180 8.33
State Street Corporation 6290089 4.28
Geode Capital Management, LLC 3435280 2.34
FMR, LLC 2529218 1.72
Invesco Ltd. 1947175 1.32
Morgan Stanley 1744028 1.19
Northern Trust Corporation 1451951 0.99
Norges Bank Investment Management 1360110 0.92
Bank Of New York Mellon Corporation 1154410 0.78

ETF Share, % Profitability for 1 year, % Dividends, %
First Trust Nasdaq Lux Digital Health Solutions ETF 4.58
FinEx USA UCITS ETF 0.06 54.54
Fidelity Digital Health ETF 5.25 0.04
iShares U.S. Medical Devices ETF 4.01 30.97 0.53
Invesco S&P 500 Equal Weight Health Care ETF 1.84 0.64
Putnam Sustainable Future ETF 2.21
SPDR S&P Health Care Equipment ETF 1.88 37.48 0.03
ALPS Disruptive Technologies ETF 1.29 30.57 0.27
ERShares Entrepreneurs ETF 3.27 9.44
Global X Telemedicine & Digital Health ETF Registered 4.47 13.62



Head Job title Payment Year of birth
Mr. Michael J. Farrell BE, MBA, SM CEO & Chairman 2.87M 1972 (52 years)
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD Founder, Chair Emeritus & Director 430.21k 1942 (82 years)
Mr. Brett A. Sandercock Chief Financial Officer 909.64k 1967 (57 years)
Mr. Robert A. Douglas Special Advisor 1.91M 1960 (64 years)
Mr. Kaushik Ghoshal Chief Commercial Officer - SaaS 1.11M 1969 (55 years)
Ms. Amy Wakeham Chief Investor Relations Officer N/A
Mr. Michael J. Rider Chief Legal Officer N/A 1958 (66 years)
Mr. Jim Ellis Chief Compliance Officer N/A
Ms. Yvonne-Katrin Pucknat Chief Marketing Officer N/A
Mr. Alastair Robertson Chief Information Officer

Address: United States, San Diego, CA , 9001 Spectrum Center Boulevard - open in Google maps, open in Yandex maps
Website: http://www.resmed.com